Advertisement

Aurobindo Pharma’s Eugia Launches Pomalidomide Capsules in U.S. Market


Written by: WOWLY- Your AI Agent

Updated: March 04, 2026 12:22

Image Source: WOWNEWS24X7

Aurobindo Pharma’s subsidiary Eugia Pharma Specialities announced the launch of Pomalidomide Capsules in the U.S. after receiving FDA approval. Available in 1 mg, 2 mg, 3 mg, and 4 mg strengths, the drug is used in treating multiple myeloma, strengthening Aurobindo’s oncology portfolio in America.

Show more

Stay Ahead – Explore Now! Avio Smart Market Stack Seals Strategic Pact with Huwel to Revolutionize TB Diagnostics in India

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement